Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Enzymatic Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover a robust biocatalytic route for (2S, 3R)-methyl phenyl glycidate using Enterobacter sp. ECU 1107, offering superior purity and scalable manufacturing for taxol synthesis.
Patent CN101157950A details enzymatic resolution for optical pure selenium-methyl selenocysteine. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN103981248B enables high-purity leucine production. Cost-effective enzymatic process ensures supply chain reliability for pharma intermediates.
Novel biocatalytic route for L-carnitine production offers >99% ee, reduced toxicity, and scalable manufacturing for reliable pharmaceutical intermediate supply chains.
Patent CN111778229B reveals high-efficiency hydrolase mutants for >99% ee production. Ideal for reliable pharma intermediate supply chains.
Patent CN104232730A details enzymatic resolution for high-purity intermediates. Achieve significant cost reduction and supply chain reliability in pharmaceutical manufacturing.
Novel enzymatic dynamic kinetic resolution for high-purity (R)-praziquantel. Reduces cost and improves supply chain reliability for API manufacturing.
Novel CvFAP mutant enables high-purity L-glufosinate synthesis via blue light catalysis, offering significant cost and supply chain advantages for herbicide manufacturers.
Patent CN115058406A reveals a novel esterase mutant for cosolvent-free l-menthol production. This breakthrough offers significant cost reduction and supply chain reliability for fine chemical manufacturers.
Patent CN107828831B details a green enzymatic route for chiral tetrahydrofuran acids, offering cost reduction and high purity for pharmaceutical intermediate manufacturing.
Patent CN1900298A details a high-yield enzymatic route for D-tyrosine. Offers >99.5% ee and scalable production for pharma intermediates.
Patent CN101611026A details a safer enzymatic route for pyrrolidine dicarboxamide derivatives, offering cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN108642119B details a lipase-catalyzed method for high-purity chiral intermediates, offering cost-effective and scalable manufacturing solutions.
Patent CN117701649B reveals enzymatic DKR for Brivaracetam intermediates. Achieve 99% ee and reduced costs. Reliable pharmaceutical intermediate supplier for scale-up.
Patent CN101679295A discloses novel hydantoins for enantiomerically pure amino acids, enabling cost-effective Ramipril and Perindopril manufacturing.
Patent CN107384980A reveals efficient Reformatsky and lipase resolution for beta-hydroxy-gamma-amino acids, offering cost reduction and supply reliability for pharma intermediates.
Patent CN1642928A details novel routes for high-purity morpholine derivatives. Discover cost-effective enzymatic and chiral pool strategies for API manufacturing.
Patent CN100463903C reveals a novel hydrolase method for producing high-purity (S)-indoline-2-carboxylic acid, offering significant cost reduction in API manufacturing.
Advanced enzymatic resolution process for high-purity pharmaceutical intermediates. Reduces cost and improves supply chain reliability for global buyers.
Patent CN115894496B reveals a green enzymatic route for Ticagrelor intermediates. Achieve high purity and cost reduction in pharmaceutical manufacturing with scalable supply.